Empower Clinics Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive TAAT News and Ratings via Email

Sign-up to receive the latest news and ratings for Empower Clinics and its competitors with MarketBeat's FREE daily newsletter.

About Empower Clinics

TAAT Global Alternatives Inc., through its subsidiary, TAAT International LLC, manufactures and distributes hemp cigarettes under the Wild Hemp brand name in Canada and the United States. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.


No headlines for this company have been tracked by

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Empower Clinics (CNSX:TAAT) Frequently Asked Questions

Is Empower Clinics a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Empower Clinics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Empower Clinics stock.
View analyst ratings for Empower Clinics
or view top-rated stocks.

What stocks does MarketBeat like better than Empower Clinics?

Wall Street analysts have given Empower Clinics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Empower Clinics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for TAAT?

1 brokerages have issued twelve-month price objectives for Empower Clinics' stock. Their forecasts range from $5.17 to $5.17. On average, they anticipate Empower Clinics' stock price to reach $5.17 in the next year.
View analysts' price targets for Empower Clinics
or view top-rated stocks among Wall Street analysts.

Who are Empower Clinics' key executives?

Empower Clinics' management team includes the following people:
  • Mr. Joel S. Dumaresq, Chairman & CFO (Age 55, Pay $240k)
  • Mr. Setti Coscarella, CEO & Director
  • Mr. Rupin Pawha, In-House Counsel
  • Mr. Paul C. Logan, Exploration Mang.
  • Mr. Timothy Corkum, Chief Revenue Officer

Who are some of Empower Clinics' key competitors?

What is Empower Clinics' stock symbol?

Empower Clinics trades on the CNSX under the ticker symbol "TAAT."

How do I buy shares of Empower Clinics?

Shares of TAAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Empower Clinics' official website?

The official website for Empower Clinics is

This page was last updated on 7/29/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.